Sort   by:  
 Page size 
UnknownBivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
Not available
S-EPMC9933930 | biostudies-literature
UnknownA Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.
Not available
S-EPMC11093671 | biostudies-literature
UnknownSafety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
Not available
S-EPMC9006787 | biostudies-literature
UnknownSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Not available
S-EPMC7745181 | biostudies-literature
UnknownSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
Not available
S-EPMC8461570 | biostudies-literature
UnknownThe setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.
Not available
S-EPMC3242744 | biostudies-literature
UnknownComparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.
Not available
S-EPMC4660025 | biostudies-literature
UnknownBreast cancer management pathways during the COVID-19 pandemic: outcomes from the UK 'Alert Level 4' phase of the B-MaP-C study.
Not available
S-EPMC7993073 | biostudies-literature
UnknownBridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study.
Not available
S-EPMC10068712 | biostudies-literature
UnknownA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Not available
S-EPMC2872173 | biostudies-literature
Sort   by:  
 Page size